Strengthens diagnostic access in Jamshedpur and surrounding regions through an advanced laboratory

Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company in India, to have achieved 100% NABL accreditation across all its laboratories, has announced the launch of its new diagnostic laboratory in Jamshedpur, Jharkhand, in collaboration with SecondMedic. The facility was inaugurated by Piyush Singh, Vice President, Thyrocare Technologies Ltd. The launch marks another step in the efforts of Thyrocare towards strengthening its diagnostic network and improving the accessibility of affordable and reliable diagnostic services across the growing markets.

The laboratory is equipped for catering to routine as well as specialised diagnostic testing requirements and is supported by trained professionals, helping to address the evolving healthcare needs of the healthcare partners and patients in the region.

The collaboration with SecondMedic further strengthens the local presence of Thyrocare in Jamshedpur, expanding the reach of its advanced and affordable diagnostic services in Jharkhand and helping people in Jamshedpur to access its quality diagnostic services, supported by timely sample processing and delivery of diagnostic reports.

The expansion is in alignment with the continued focus of Thyrocare in strengthening its presence beyond the key metropolitan markets, thereby leading to a more accessible and extensive diagnostic network.

Sharing his thoughts on the launch of the new diagnostic laboratory of Thyrocare in Jamshedpur, Mr Rahul Guha, MD and CEO, Thyrocare, said, “At Thyrocare, our focus has always been on making quality and trustworthy diagnostic services more accessible to people across India. The launch of our laboratory in Jamshedpur, in partnership with SecondMedic, is another step towards making our presence strong in the emerging markets and bringing our technology-led diagnostic capabilities closer to patients. We remain committed to building a network, combining affordability, quality, and accessibility for supporting both ongoing and preventive healthcare needs.”

Rajdeep Panwar, Chief Commercial Officer, Thyrocare, said, “Jamshedpur serves as an important market for us as we continue to expand our reach across eastern India. The introduction of our new laboratory, in collaboration with SecondMedic in Jamshedpur, will help us in strengthening our local diagnostic capabilities while maintaining the turnaround and quality standards associated with Thyrocare. Through this expansion, we have the objective of increasing the accessibility of reliable diagnostic services to the patients and healthcare partners across Jamshedpur and the neighbouring regions.”

With the launch of its new laboratory in Jamshedpur, Thyrocare continues to strengthen its diagnostic footprint across India, with a focus on expanding access to standard and affordable testing beyond the metro markets.

About Thyrocare

Thyrocare Technologies Limited (NSE: THYROCARE, BSE: 539871) is India’s first and foremost advanced, fully automated laboratory chain with a strong presence across India. Thyrocare focuses on providing quality and affordable diagnostic services to laboratories and hospitals. Many laboratories and hospital brands all over India use the comprehensive test profile menu offered by Thyrocare.

Thyrocare has an extensive network of laboratories across PAN India. Thyrocare has a quarterly active franchise count of 10,000+ and processed 53.3 million+ diagnostic and screening investigations in Q2FY26.

Thyrocare is one of the first Indian diagnostic laboratories to obtain internationally renowned quality accreditations, including an ISO 9001-2000 rating as early as 2001, which was upgraded to ISO 9001:2015 and National Accreditation Board for Testing and Calibration Laboratories (NABL) and College of American Pathologists (CAP) accreditations in 2005.